Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses the role primary care will play in the transition to value-based care.
Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses the role primary care will play in the transition to value-based care.
Transcript
What role will primary care play in the transition to value-based care and do you think this role will continue to evolve?
Primary care’s been huge in value-based care, and it’s been interesting. We started our patient-centered medical homes many, many years ago and have continued to invest in them. We have a pharmacist, a behaviorist, and care and case managers in those homes, and we do that to deliver better care for our population. I think there’s still a next iteration. We’re now looking at a patient-centered medical mome 2.0 where we really try to take the burden off of the physicians. We’ve put a lot of work in there, we’ve put a team in there, but it still can be overwhelming. So, now we’re looking at how do we move the work to the appropriate licensed individual? How do we free up the physician to really focus on the relationship they have with patients and on populations? So, we’re really re-tooling a lot of the clinical processes along with analytics.
Additionally, in the future, I think the primary care clinics are going to need more data. They can’t just be your diabetes bundle, they can’t just be your medication adherence for depression. We need much more. We need to understand who are our patients, what do they need, and how to best engage them. So, I think the data analytics will play a role in that and continue to see primary care really lead in population health and in total cost of care.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
The Role of Transplant in the Era of Novel MM Therapies: Harsh Parmar, MD
May 17th 2025Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't replaced stem cell transplantation, Harsh Parmar, MD, of Hackensack University Medical Center, explains.
Read More
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More